^
CANCER:
Neuroendocrine Tumor
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
sunitinib
Sensitive
:
D
Transl Oncol - 2wk
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
crizotinib + sunitinib
Sensitive
:
D
Transl Oncol - 2wk
TYRO3 mutation + ALK mutation
Neuroendocrine Tumor
crizotinib
Resistant
:
D
Transl Oncol - 2wk
MSI-H/dMMR
Neuroendocrine Tumor
pembrolizumab
Sensitive
:
A2
NCCN - 3wk
TMB-H
Neuroendocrine Tumor
pembrolizumab
Sensitive
:
A2
NCCN - 3wk
No biomarker
Neuroendocrine Tumor
surufatinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
everolimus
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
lanreotide prolonged-release subcutaneous
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
EP
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
octreotide
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
temozolomide
Sensitive
:
A2
SSTR positive
Neuroendocrine Tumor
lanreotide prolonged-release subcutaneous
Sensitive
:
A2
SSTR positive
Neuroendocrine Tumor
octreotide
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
FOLFOX
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
temozolomide + capecitabine
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
oxaliplatin
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
dacarbazine
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
cisplatin + etoposide IV
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
5-fluorouracil
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
capecitabine
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
pembrolizumab
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
FOLFIRINOX
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
carboplatin + irinotecan
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
cisplatin + irinotecan
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
FOLFIRI
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our